subcutaneously

简明释义

英[ˌsʌbkjuˈteɪniəsli]美[ˌsʌbkjuˈteɪniəsli]

adv. 皮下地

英英释义

单词用法

同义词

反义词

例句

1.Methods: Senile rats model was established by adopting the method that injected D-galactose subcutaneously in nape.

方法：采用D -半乳糖颈后皮下注射的方法，造成亚急性衰老动物模型。

2.METHODS: Mouse lymphoma EL4 cells were inoculated subcutaneously into wild type C57BL/6 mice (immune-competent mice).

方法：给正常野生型C57BL/6小鼠皮下接种小鼠淋巴瘤EL4细胞，建立荷EL4肿瘤的小鼠模型。

3.Unfortunately, not all of these patients are able to have someone who can give subcutaneous injections and these drugs can only be given either intravenously or subcutaneously.

不幸的是，并非所有患者身边都有人可以帮他们进行皮下注射，而这些药物只能通过静脉或皮下给药。

4.Desensitiztion is carried out by giving small doses of highly diluted antitoxin subcutaneously at first.

敏，是通过给予小剂量高度稀释抗毒素皮下注射进行的。

5.These two cells were subcutaneously inoculated into nude mice, and the tumorigenesis was observed.

并将两种细胞接种于裸鼠皮下，观察移植瘤的形成情况。

6.METHODS the model of fevered rat was prepared by yeast injected subcutaneously and the model of fevered rabbit was prepared by endotoxin injected intravenously.

方法：采用干酵母所致大鼠发热模型及内毒素所致家兔发热模型，观察北柴胡及春柴胡的解热作用。

7.The medication was administered subcutaneously to ensure faster absorption.

药物被以皮下方式给药，以确保更快的吸收。

8.Patients with diabetes often inject insulin subcutaneously to control their blood sugar levels.

糖尿病患者通常将胰岛素皮下注射，以控制血糖水平。

9.The vaccine is given subcutaneously to stimulate an immune response.

疫苗通过皮下方式接种，以刺激免疫反应。

10.For the study, the drug was delivered subcutaneously rather than orally.

在这项研究中，药物通过皮下方式给药，而不是口服。

11.The veterinarian recommended that the cat receive the treatment subcutaneously for better results.

兽医建议猫咪接受皮下治疗以获得更好的效果。

作文

In the field of medicine, the administration of drugs can occur through various routes. Among these methods, injecting medications subcutaneously is a common practice that offers several advantages. This method involves delivering medication into the layer of fat and tissue just beneath the skin, which is known as the subcutaneous tissue. By understanding how to effectively use this method, healthcare professionals can optimize treatment outcomes for patients. One of the primary benefits of administering drugs subcutaneously is the ease of the procedure. Compared to intravenous (IV) injections, which require more training and sterile conditions, subcutaneously delivered medications can often be administered by patients themselves after receiving proper guidance from their healthcare providers. This self-administration capability empowers patients, particularly those with chronic conditions like diabetes, who may need to inject insulin regularly. The convenience of subcutaneously administered medications allows for better adherence to treatment regimens, ultimately leading to improved health outcomes. Another advantage of subcutaneously administered medications is the sustained release they can provide. Certain drugs are formulated to be absorbed slowly from the subcutaneous tissue, allowing for a prolonged therapeutic effect. This is particularly beneficial for medications that need to maintain stable blood levels over an extended period. For instance, some hormonal therapies and anticoagulants are designed to be injected subcutaneously, providing a steady release of the active ingredient into the bloodstream. However, there are also challenges associated with subcutaneously administered medications. One concern is the potential for local reactions at the injection site, such as redness, swelling, or pain. These reactions can discourage patients from continuing their treatment. Healthcare providers must educate patients about proper injection techniques and site rotation to minimize these adverse effects. Additionally, certain medications may not be suitable for subcutaneously administration due to their chemical properties or the required dosage volume, necessitating alternative routes of delivery. Furthermore, the choice of needle size and injection technique can significantly affect the absorption rate of subcutaneously administered drugs. Thinner needles may reduce discomfort but could also impact how quickly the medication enters the bloodstream. Healthcare professionals must carefully consider these factors when prescribing treatments that involve subcutaneously administered medications. In conclusion, the use of subcutaneously administered medications represents a valuable option in modern medical practice. With its ease of administration, potential for sustained release, and ability to enhance patient autonomy, this method has become increasingly popular. However, it is essential for both healthcare providers and patients to understand the potential challenges and best practices associated with subcutaneously delivering medications. As research continues to advance, we can expect to see even more innovations in drug delivery methods, further improving patient care and treatment efficacy.

在医学领域，药物的给药方式可以通过多种途径进行。在这些方法中，皮下注射药物是一种常见的实践，它提供了几项优势。这种方法涉及将药物注入皮肤下方的脂肪和组织层，即皮下组织。通过理解如何有效地使用这种方法，医疗专业人员可以优化患者的治疗效果。 皮下注射药物的主要好处之一是操作的简便性。与需要更多培训和无菌条件的静脉（IV）注射相比，皮下注射的药物通常可以在接受医疗提供者的适当指导后由患者自行施用。这种自我施用能力使患者感到更有权力，尤其是那些需要定期注射胰岛素的糖尿病患者。皮下注射药物的便利性有助于更好地遵循治疗方案，最终改善健康结果。 另外，皮下注射药物还提供了持续释放的优势。某些药物被配制为从皮下组织缓慢吸收，从而允许药物的治疗效果延续较长时间。这对于需要在较长时间内维持稳定血药浓度的药物尤为有利。例如，一些激素疗法和抗凝剂设计为皮下注射，提供活性成分进入血液的稳定释放。 然而，与皮下注射药物相关的挑战也存在。一个问题是注射部位可能出现局部反应，例如红肿或疼痛。这些反应可能会使患者不愿继续治疗。医疗提供者必须教育患者关于适当的注射技巧和部位轮换，以尽量减少这些不良反应。此外，某些药物由于其化学性质或所需剂量体积可能不适合皮下注射，因此需要其他给药途径。 此外，针头大小和注射技术的选择会显著影响皮下注射药物的吸收率。更细的针头可能减少不适感，但也可能影响药物进入血流的速度。医疗专业人员在开处方涉及皮下注射药物的治疗时，必须仔细考虑这些因素。 总之，使用皮下注射药物代表了现代医学实践中的一种宝贵选择。由于其易于施用、潜在的持续释放和增强患者自主性的能力，这种方法变得越来越受欢迎。然而，医疗提供者和患者都必须理解与皮下注射药物给药相关的潜在挑战和最佳实践。随着研究的不断进展，我们可以期待在药物输送方法上看到更多创新，进一步改善患者护理和治疗效果。